Date post: | 20-Jan-2015 |
Category: |
Documents |
Upload: | d-warnick-consulting |
View: | 79 times |
Download: | 0 times |
Benchmarking Survey Working Group Update
Presented byHeather Guerrero, MA, CCMEPGilead Sciences, Inc.
Karen Dzenko, Boehringer-Ingelheim
Benchmarking Survey Working Group
Beth Page, Lilly
Karen Dzenko, Boehringer-Ingelheim
Co-chairs
Riaz Baxamusa, AstellasKristan Cline, NPS PharmaceuticalsJill Erickson, TakedaHeather Guerrero, Gilead SciencesPatty Jassak, Astellas, (IACE Lead
Elect)Pamela Mason, AstraZenecaApril Pond, TalecrisJanet Moga – GenentechJulia Shklovskaya – TakedaNancy Santilli – Independent Contractor
MembersIACE and ACEHP Leadership
Jason Singer, IACE Lead, Lilly
Christine Amorosi RN MHSA, Division Director - Quality & Innovation
Survey Content
- Department Scope and Budgets- Grant Review and Approval Process
- Nature of Interactions with Providers- Educational Value
- Future Trends
IME Focus Areas Ranked Important to PACME Leadership
Developing the Survey
2009
• 6 organizations represented on Working Group• Identified need to benchmark practices and processes related to Industry funding of
educational grants as a framework for future surveys
Design
• Survey Development (Spring 2009-Spring 2010)• Questions for each focus area were developed, reviewed and revised for clarity and accuracy • Survey was beta-tested by the PACME Leadership Group and refined• Survey consisted of 53 questions – and required approx. 45 minutes to complete
Today
• 12 organizations represented on Working Group• Same survey dissemination process as in 2009
•Survey link was sent to one key individual per organization from the IACE (formerly PACME) membership list•Three reminder notices sent to distribution list•Anonymity guaranteed through use of Zoomerang (now Survey Monkey) platform
What the BWG Has Delivered
• Inaugural year of the Benchmarking Insights in 2013• Almanac publications in 2012 and 2013• Policy and Medicine communication February 2014
• Annual survey since 2010• Two additional surveys focusing on monitoring and
outcomes in 2011
• 8 presentations • Presented at the IACE Summit, Task Force, CME
Congress and CBIPresentations
Surveys
Publications
New Look and Feel to Insights Report
How Does Your Organization Use this Data?
Outcomes
Grant review cycle
Grants
Resource/staffing
Value CME
Budget
RFP/CGA
Monitoring
Process/SOP
0 1 2 3 4 5 6 7 8
67% improve organizational process
29% validate organizational process 14% compare against other companies
Free Text Response Answering How Survey Respondents Utilized the Data
2013 Survey
“Organization data was compared against the benchmarking data; improved grant processes to reflect majority of industry.”
“Validates some thinking on areas (ie budgeting, processes).”
“Staffing; evolution of department’s roles and responsibilities.”
“Add monitoring. Increased outcomes expectations. Expand scope of reporting.”“Confirm processes to ensure validation of activities within our organization across the industry.”
“Use of RFPs including information to be included on RFPs and posting options.”“We use the data internally to champion the value of CME message, justify additional resources, and to benchmark processes (like monitoring) within industry. Its a very valuable tool!”
Using the Data
• Insights from Karen and Heather and how their organizations use the data from the survey
• Any input from the attendees about ways they have used the data in their organization?
• Any future topics you would like to see addressed?Discussion
Case Studies
Deeper Dive in the 2014 Survey
Grants review committee
New topic
• Open Payment • Satellite symposia• Single support /multiple support• RFP/CGA• Change of scope • Monitoring• Outcomes
Topics Explored at Greater Depth
For More Information About Survey Participation or a Copy of the
Benchmarking Report
Text to: 281-660-3794
Device companies to be added to survey recipients
Pharma companies to be added to survey recipients
Update contact information
Questions or suggestions